Quick search:
| Result | Content | Outlet | Published | Research |
|---|---|---|---|---|
| Result | Content | Outlet | Published | Research |
| 1 | COVID-19 Global Rheumatology Alliance registry to close after leaving 'enormous impact' | Healio | 3 months ago |
|
| 2 | COVID‐19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID‐19 Global Rheumatology Alliance (C19‐GRA) physician registry | Wiley | 3 months ago |
|
| 3 | Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study | The Lancet | 9 months ago |
|
| 4 | COVID-19 global registry data key in rheumatic disease management | Healio | 2 months ago |
|
| 5 | How COVID-19, Long COVID, and COVID Vaccines Differ Between Males and Females | CreakyJoints | 24 days ago |
|
| 6 | Obesity Increases Risk of COVID-19 Hospitalization in Juvenile Patients | Rheumatology Network | 25 days ago |
|
| 7 | Clinical Characteristics of Patients With Rheumatic Disease With Breakthrough COVID-19 Assessed | Rheumatology Advisor | 4 months ago |
|
| 8 | Initial data from the COVID-19 Global Rheumatology Alliance provider registries | The Lancet | 2 years ago |
|
| 9 | Global Registry Aims to Determine Disease Patterns in Rheumatic Disease and COVID-19 Using Real-World Data | Rheumatology Advisor | 2 years ago |
|
| 10 | Jean Liew, MD, MS: COVID-19 Infections Among Vaccinated Individuals with Rheumatic Disease | Rheumatology Network | 10 months ago |
|
| 11 | Disease flares requiring therapy change 'relatively uncommon' after COVID-19 vaccination | Healio | 2 months ago |
|
| 12 | COVID and Inflammatory Arthritis: What You Should Know | Hospital for Special Surgery | 6 months ago |
|
| 13 | Systemic Lupus Erythematosus: Certain Factors Drive Severe COVID-19 Outcomes | Rheumatology Advisor | 5 months ago |
|
| 14 | Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform | The Lancet | 2 months ago |
|
| 15 | Gout increases risk for COVID-19-related death | Healio | 3 months ago |
|
| 16 | Some Patients on Sulfasalazine May Be at Greater Risk for Severe COVID | CreakyJoints | 5 months ago |
|
| 17 | Lisa Sammaritano, MD, Talks About COVID-19, Pregnancy, and Rheumatic Disease – What We Know So Far | Rheumatology Advisor | 7 months ago |
|
| 18 | New points for therapeutic drug monitoring in people with rheumatic disease | Medical Xpress | 3 months ago |
|
| 19 | Interview: Suleman Bhana, MD, Talks About COVID-19 Global Rheumatology Alliance | DocWire News | 2 years ago |
|
| 20 | Initial Findings on Lupus and COVID-19 Now Available | Lupus Foundation of America | 2 years ago |
|
| 21 | Characteristics and Obstetric Outcomes in Women With Autoimmune Rheumatic Disease During the COVID-19 Pandemic in Qatar | Cureus | 4 months ago |
|
| 22 | Favorable COVID-19 Outcomes in Pregnant Women With Rheumatic Disease | Rheumatology Network | 11 months ago |
|
| 23 | Jean Liew, MD, MS, Discusses COVID-19 Vaccine Efficacy in Patients with Rheumatic Disease | MD Magazine | 9 months ago |
|
| 24 | Treatment resistance of rheumatoid arthritis relates to infection of periodontal pathogenic bacteria: a case–control cross-sectional study | Scientific Reports | Nature.com | 27 days ago |
|
| 25 | Nearly 30% of those with rheumatic disease saw employment change early in COVID-19 pandemic | Healio | 1 year ago |
|
| 26 | Severe COVID-19 Outcomes Rare Among Children and Young People With Rheumatic Diseases | Rheumatology Advisor | 4 months ago |
|
| 27 | Covid-19: surging demand for some arthritis drugs | The BMJ | 9 months ago |
|
| 28 | Alpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2022 Financial Results | Business Wire | 4 days ago |
|
| 29 | Vaccinated yet vulnerable: COVID-19 and the immunocompromised patient | Healio | 10 months ago |
|
| 30 | Certain RA Medications May Prevent and Treat COVID-19 | Verywell Health | 2 years ago |
|
| 31 | COVID Death: Which Rheumatic Patients Are at Risk? | Medpage Today | 1 year ago |
|
| 32 | AbbVie Reports Second-Quarter 2022 Financial Results | AbbVie News Center | AbbVie | 17 days ago |
|
| 33 | Baseline rituximab, JAK inhibitor use linked to worse COVID-19 severity in patients with RA | Healio | 1 year ago |
|
| 34 | Worse COVID-19 outcomes in lupus driven by demographics, untreated disease | Healio | 5 months ago |
|
| 35 | COVID-19 therapeutics: Challenges and directions for the future | Proceedings of the National Academy of Sciences | pnas.org | 4 months ago |
|
| 36 | Risk for 'more severe, critical' COVID-19 higher in RA vs. PsA, ulcerative colitis | Healio | 7 months ago |
|
| 37 | Do Some Arthritis, IBD Drugs Put Patients at Greater COVID Risk? | Medpage Today | 10 months ago |
|
| 38 | MIMEDX Announces Formation of Regenerative Medicine Scientific Advisory Board Comprised of Renowned Industry and Academic Experts | BioSpace | 19 days ago |
|
| 39 | Clinical Challenges: Psoriatic Arthritis and COVID-19 | MedPage Today | Medpage Today | 9 months ago |
|
| 40 | 8 Noteworthy COVID-19 Studies from EULAR 2022 | CreakyJoints | 2 months ago |
|
| 41 | Moderate, high dose steroids linked to more severe COVID-19 | Healio | 2 years ago |
|
| 42 | Breakthrough COVID-19 in vaccinated patients linked to B-cell therapies, mycophenolate | Healio | 9 months ago |
|
| 43 | Pfizer COVID Vax Performs Well in Youth With Rheumatic Diseases | Medscape | 3 months ago |
|
| 44 | Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐Analysis | Wiley | 2 years ago |
|
| 45 | The Top 100 Healthcare Technology Companies of 2022 | The Healthcare Technology Report. | 12 days ago |
|
| 46 | Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab | BMJ | 8 months ago |
|
| 47 | Study Sheds Light on What Matters Most to Those with Rheumatic Disease | CreakyJoints | 2 months ago |
|
| 48 | Arthritis News You Can Use EULAR 2022 | Everyday Health | 2 months ago |
|
| 49 | BMJ Rheumatology Hub | BMJ | The BMJ | 10 months ago |
|
| 50 | AbbVie Showcases its Leadership in Rheumatology Research with New Data Across Multiple Inflammatory Joint Diseases at the EULAR 2022 Congress | AbbVie News Center | AbbVie | 3 months ago |
|
| 51 | Shifting 'definition of fully vaccinated' muddles COVID-19 vaccine efficacy data for IMIDs | Healio | 6 months ago |
|
| 52 | Family Doctor Contracted Service with Chronic Disease | PPA | Dove Medical Press | 3 days ago |
|
| 53 | Patients With Rheumatic Diseases at No Greater Risk of Contracting COVID-19 | AJMC.com Managed Markets Network | 2 years ago |
|
| 54 | Defining the highest-risk clinical subgroups upon community infection with SARS-CoV-2 when considering the use of neutralising monoclonal antibodies (nMABs) and antiviral drugs: independent advisory group report | GOV.UK | 3 months ago |
|
| 55 | House Leadership Urged to Reauthorize Program to Retain Needed Physicians | AHA | American Hospital Association | 14 days ago |
|
| 56 | Moderate, high rheumatic disease activity linked to higher risk for COVID-related death | Healio | 1 year ago |
|
| 57 | Rheumatic Patients in Africa, Asia Faced Hydroxychloroquine Shortage due to COVID-19 | MD Magazine | 2 years ago |
|
| 58 | ACELYRIN, INC., Affibody AB and Inmagene Biopharmaceuticals Announce Data from Global Phase 2 Trial of Izokibep in Patients with Psoriatic Arthritis Presented During 2022 European Alliance of Associations for Rheumatology Congress | PR Newswire | 2 months ago |
|
| 59 | EULAR 2021: Arthritis Research Updates for Patients | CreakyJoints | 1 year ago |
|
| 60 | Rheumatoid arthritis: Understanding racial disparities in care | Medical News Today | 5 months ago |
|
| 61 | Rheumatoid Arthritis and COVID-19 Vaccination: Questions and Answers | Everyday Health | 2 months ago |
|
| 62 | Hydroxychloroquine fails to prevent COVID-19 in patients with lupus | Healio | 2 years ago |
|
| 63 | Children With RMDs Not at High Risk for Severe COVID-19, Study Finds | Medscape | 4 months ago |
|
| 64 | COVID-19 study good news for rheumatic disease patients on immunosuppressants | The University of Manchester | 2 years ago |
|
| 65 | Aurinia Announces Positive CHMP Opinion for LUPKYNIS® (voclosporin) for the Treatment of Adults with Active Lupus Nephritis in Europe | Yahoo Finance | 24 days ago |
|
| 66 | COVID Vaccination Guidelines for People with Rheumatic Disease | PracticalPainManagement.com | 6 months ago |
|
| 67 | High-Titer Rheumatoid Factor, Anticitrullinated Peptide Antibody May Increase Risk for Poor Outcomes | Rheumatology Advisor | 3 months ago |
|
| 68 | COVID-19 hospital admission rare for children with arthritis | The University of Manchester | 5 months ago |
|
| 69 | From Pandemic to Endemic | Contagionlive.com | 6 months ago |
|
| 70 | Inflammatory Rheumatic Diseases: Challenges in Treating Older Adults | Rheumatology Advisor | 3 months ago |
|
| 71 | Delayed Identification of RA in Patients With Autoantibody Negativity | Rheumatology Advisor | 3 months ago |
|
| 72 | Trump Talks Up Drug That Increases Risk of Cardiac Arrest | The Intercept | 2 years ago |
|
| 73 | First key steps in pipeline rebuild and strong commercial progress in H1 2022 | GlobeNewswire | 11 days ago |
|
| 74 | Telemedicine: is the new normal fit for purpose? | The Lancet | 8 months ago |
|
| 75 | New Study Explores Why Language Nuances Matter in Good Rheumatic Care | CreakyJoints | 5 months ago |
|
| 76 | Treating rheumatoid arthritis with immune suppression | Medical News Today | 5 months ago |
|
| 77 | Impact of the COVID-19 pandemic on uveitis patient care | British Journal of Ophthalmology | 7 months ago |
|
| 78 | Q&A: Overview of COVID-19 in Patients With Autoimmune Diseases | Rheumatology Advisor | 2 years ago |
|
| 79 | Methotrexate Initiated at Pre-RA Stage of Symptoms Modifies Disease Course | Rheumatology Advisor | 2 months ago |
|
| 80 | Leonard Calabrese, DO: Autoimmune Diseases and COVID-19 as Immunology | Rheumatology Network | 1 year ago |
|
| 81 | 'Fire hydrant' of COVID-19 data tasks clinicians with conflicting evidence, mixed results | Healio | 1 year ago |
|
| 82 | Identification of Risk Factors for COVID‐19 Hospitalization in Patients With Anti‐Rheumatic Drugs: Results From a Multicenter Nested Case Control Study | Wiley | 6 months ago |
|
| 83 | Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study | The Lancet | 9 months ago |
|
| 84 | New Information on COVID-19 Hospitalization Risk among People with Lupus | Lupus Foundation of America | 2 years ago |
|
| 85 | Patient-Provider Satisfaction Survey Affected by Cultural Norms in Hispanic/Latinx Patients with RA | Rheumatology Network | 2 months ago |
|
| 86 | Steroid use increases COVID-19 hospitalization risk for patients with rheumatic diseases | Healio | 2 years ago |
|
| 87 | Are People with Lupus Protected Against COVID-19? | Lupus Foundation of America | 2 years ago |
|
| 88 | Trump's False Coronavirus Claim About Lupus Patients | FactCheck.org | 2 years ago |
|
| 89 | Systemic autoimmune rheumatic disease linked to higher end-organ failure risk in COVID-19 | Healio | 2 years ago |
|
| 90 | Health Checklists and Resources for Living With Rheumatoid Arthritis During the Coronavirus Pandemic | Everyday Health | 2 years ago |
|
| 91 | Immunogenicity of COVID vaccines in people with rheumatic disease | EurekAlert | 2 months ago |
|
| 92 | Efficacy vs. effectiveness: Registry data key to which drugs are useful in real world | Healio | 3 months ago |
|
| 93 | Guidance on Chronic Illness and the COVID 19 Vaccine | The Doctor Weighs In | 1 year ago |
|
| 94 | COVID therapies needed beyond vaccine: Role of monoclonal antibodies, convalescent plasma? | Healio | 2 years ago |
|
| 95 | Methotrexate May Interfere With Covid-19 Vaccine | Everyday Health | 1 year ago |
|
| 96 | Duke Event Calendar | Duke University | 1 month ago |
|
| 97 | Filip Van den Bosch, MD: Upadacitinib for Non-radiographic Axial Spondyloarthritis | MD Magazine | 2 months ago |
|
| 98 | What's Preventing Patients from Hitting Treatment Targets? | CreakyJoints | 5 months ago |
|
| 99 | Amerisourcebergen Corp (ABC) CEO Steven Collis on Q3 2022 Results | Earnings Call Transcript | 12 days ago |
|
| 100 | How the Hydroxychloroquine Shortage Is Hurting People with RA | Healthline | 2 years ago |
|